Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists

被引：0
|
作者：
Shah, U
Boyle, CD
Chackalamannil, S
Neustadt, B
Foster, C
Arik, L
Zhai, Y
Lachowicz, JE
Ng, K
Shiyong, W
Monopoli, A
Ongini, E
机构：
[1] Schering Plough Corp, CNS CV Chem Res, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, CNS Dept Biol Res, Kenilworth, NJ 07033 USA
[3] Schering Plough Corp, Drug Metab & Pharmacokinet, Kenilworth, NJ 07033 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
MEDI-76
引用
收藏
页码：U2549 / U2550
页数：2
相关论文
共 50 条
  • [1] Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists
    Shah, Unmesh
    Boyle, Craig D.
    Chackalamannil, Samuel
    Neustadt, Bernard R.
    Lindo, Neil
    Greenlee, William J.
    Foster, Carolyn
    Arik, Leyla
    Zhai, Ying
    Ng, Kwokei
    Wang, Shiyong
    Monopoli, Angela
    Lachowicz, Jean E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4199 - 4203
  • [2] SCH 58261:: A selective A2A adenosine receptor antagonist
    Ongini, E
    [J]. DRUG DEVELOPMENT RESEARCH, 1997, 42 (02) : 63 - 70
  • [3] Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists
    Shah, Unmesh
    Lankin, Claire M.
    Boyle, Craig D.
    Chackalamannil, Samuel
    Greenlee, William J.
    Neustadt, Bernard R.
    Cohen-Williams, Mary E.
    Higgins, Guy A.
    Ng, Kwokei
    Varty, Geoffrey B.
    Zhang, Hongtao
    Lachowicz, Jean E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4204 - 4209
  • [4] Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat
    Monopoli, A
    Casati, C
    Lozza, G
    Forlani, A
    Ongini, E
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 285 (01): : 9 - 15
  • [5] Novel triazolopyrazine, triazolopyrimidine, and triazolotriazine derivatives as potent and selective adenosine A2a receptor antagonists
    Kumaravel, Gnanasambandam
    Engber, Thomas
    Vu, Chi B.
    Peng, Hairuo
    Dowling, James E.
    Yao, Gang
    Vessels, Jeffery T.
    Scott, Daniel
    Petter, Russell C.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [6] SCH-58261, A NEW POTENT AND SELECTIVE ADENOSINE-A(2A) RECEPTOR ANTAGONIST
    ZOCCHI, C
    ONGINI, E
    BARALDI, PG
    DIONISOTTI, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P299 - P299
  • [7] Selective adenosine A2A receptor antagonists
    Ongini, E
    Monopoli, A
    Cacciari, B
    Baraldi, PG
    [J]. FARMACO, 2001, 56 (1-2): : 87 - 90
  • [8] [3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies
    Fredholm, BB
    Lindström, K
    Dionisotti, S
    Ongini, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 1998, 70 (03) : 1210 - 1216
  • [9] Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
    Zhu, Chenyu
    Ze, Shuyin
    Zhou, Ronghui
    Yang, Xinyu
    Wang, Haojie
    Chai, Xiaolei
    Fang, Meimiao
    Liu, Mingyao
    Wang, Yonghui
    Lu, Weiqiang
    Xie, Qiong
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 4734 - 4754
  • [10] Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists
    Peng, HR
    Kumaravel, G
    Yao, G
    Sha, L
    Wang, J
    Van Vlijmen, H
    Bohnert, T
    Huang, C
    Vu, CB
    Ensinger, CL
    Chang, HX
    Engber, TM
    Whalley, ET
    Petter, RC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) : 6218 - 6229
12345